miércoles, 13 de octubre de 2021

Association of Receipt of the Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barré Syndrome, February-July 2021 | Clinical Pharmacy and Pharmacology | JAMA | JAMA Network

Association of Receipt of the Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barré Syndrome, February-July 2021 | Clinical Pharmacy and Pharmacology | JAMA | JAMA Network
Publicado por en

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)